Following a public comment period, the Federal Trade Commission has approved a final order settling charges that global medical technology company Medtronic, Inc.’s $42.9 billion acquisition of Covidien plc would likely be anticompetitive. Under the order, first announced in November 2014, the companies agreed to sell Covidien’s drug-coated balloon catheter business to a Colorado-based medical […]
Tag Archives: Health Care Medical Equipment and Devices Bureau of Competition Competition Merger
FTC Puts Conditions on Medtronic’s Proposed Acquisition of Covidien
Global medical technology company Medtronic, Inc. has agreed to divest the drug-coated balloon catheter business of Ireland-based medical products company Covidien plc, in order to settle Federal Trade Commission charges that its $42.9 billion acquisition of Covidien would likely be anticompetitive. Under the FTC’s proposed settlement, Medtronic will sell the drug-coated balloon catheter business to […]